
|
WEEKLY REPORT |
|---|
|
Allowing either tetanus toxoid, reduced diphtheria toxoid, and acellular (Tdap) or tetanus and diphtheria toxoids (Td) to be used in situations where Td only was previously recommended increases provider point-of-care flexibility. |
|---|
|
|
|---|
|
|
|---|
|
QUICKSTATS |
|---|
|
CONTINUING EDUCATION |
|---|
|
|
|---|


